Radiation Oncology/Therapy: Page 122

Accuray posts Q3 results, taps new CCO

By AuntMinnie.com staff writers

Radiation oncology firm Accuray posted declines in its Q3 revenue and net profit and also announced a new executive position, chief commercial officer (CCO).

April 27, 2017

Varian adds to revenues in Q2

By AuntMinnie.com staff writers

Revenue growth in its Oncology Systems business propelled radiation oncology firm Varian Medical Systems to higher levels in the company's second quarter of fiscal year 2017.

April 26, 2017

SPECT/CT can solve renal cell carcinoma diagnosis conundrum

By Wayne Forrest

By turning to a SPECT/CT scan with technetium-99m sestamibi, clinicians can overcome inconclusive or suspicious CT or MRI results and are better able to characterize and diagnose renal cell carcinoma, according to a study published in the April issue of Clinical Nuclear Medicine.

April 26, 2017

iCAD to highlight Xoft clinical results at ABS

By AuntMinnie.com staff writers

Computer-aided detection (CAD) developer iCAD plans to highlight clinical results regarding the use of its Xoft Axxent brachytherapy system for intraoperative radiation therapy at the upcoming American Brachytherapy Society (ABS) meeting in Boston.

April 19, 2017

ASTRO releases oropharyngeal cancer guidelines

By AuntMinnie.com staff writers

The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for managing oropharyngeal cancer in the society's clinical practice journal, Practical Radiation Oncology.

April 16, 2017

ViewRay boosts borrowing capacity

By AuntMinnie.com staff writers

Image-guided radiation therapy developer ViewRay has increased the borrowing capacity on its loan with healthcare investment firm CRG.

April 13, 2017